Black Friday Sale! Save huge on InvestingProGet up to 60% off

BRIEF-InSite Vision says enters merger agreement with Sun Pharma for $0.35 per share

Published 2015-09-15, 04:55 p/m
© Reuters.  BRIEF-InSite Vision says enters merger agreement with Sun Pharma for $0.35 per share

Sept 15 (Reuters) - InSite Vision Inc:
* Says deal for approximately $48 million in aggregate equity value, on a fully
diluted basis
* Says terminates merger agreement with QLT Inc
* Insite vision-co, unit of Sun pharma industries entered agreement under which
indirect unit of Sun pharma will acquire co in an all-cash transaction
* Says deal for $0.35 per share
* Says board determined that the Sun pharma transaction represented a company
superior proposal under the QLT merger agreement
* Co was required to pay $2.7 million termination fee to QLT;the Sun pharma
subsidiary has paid this fee to QLT on insite's behalf

* Source text for Eikon ID:nBw7gQGFpa

* Further company coverage INSV.PK

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.